SANTA CLARA, Calif., — Affymetrix Inc. (Nasdaq:AFFX) announced today the launch of the GeneChip(R) Human Tiling 1.0R Array Set and Mouse 1.1R Array Set, the only commercially available microarrays for whole-genome transcript mapping. These new arrays look far beyond the known protein-coding genes to deliver the most detailed and unbiased view of the entire human […]
PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, and Luminex(R) Corporation (Nasdaq: LMNX), a leading multiplex solution developer, announced today a long-term licensing agreement to provide PerkinElmer access to Luminex’s xMAP(R) technology and assay development capabilities of the Luminex Bioscience Group. Under the terms of the agreement, […]
CARLSBAD, Calif.,– Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced that its subsidiary, Invitrogen Federal Systems, was awarded a $970K Technical Assistance Agreement by the U.S. Department of Defense to produce and validate protein microarrays to biothreat agents. This work will be conducted under the […]
Newport Beach, CA —Acacia Research has approved a plan for its CombiMatrix subsidiary, a maker of DNA microarray consumables and instrumentation,to become an independent public company. The transaction is expected to be completed in the second quarter of 2006 with CombiMatrix listing its shares on the NASDAQ exchange. “This will benefit both companies by eliminating […]
Santa Clara, CA 1/5/05—Affymetrix has announced that it expects fourth quarter 2005 revenues of $115 million, $15 million below the company’s previous guidance of $120 million. Affymetrix estimates 2005 total revenues of $365 million, for annual growth of 5.5%, and 2005 product and product-related revenues of $350 million, for growth of 5.7%. In 2006, Affymetrix […]
Platform Enables Researchers to Profile All Known miRNAs from Humans Plus Additional Human Predicted miRNAs and Most Studied Genomes CARLSBAD, Calif.–Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today introduced its NCode(TM) microRNA (miRNA) Microarray platform. The NCode(TM) […]
SANTA CLARA, Calif..–Affymetrix Inc. (Nasdaq:AFFX) today announced the completion of its acquisition of privately held ParAllele BioScience, Inc., a provider of highly-scalable technology for comprehensive genetic studies. In connection with the completion of the acquisition, ParAllele stockholders will receive approximately $120.8 million in the form of approximately 2.29 million shares of Affymetrix common stock and […]
AUSTIN, Texas, Luminex Corporation (Nasdaq: LMNX – News) today announced the immediate availability of the Luminex 200, the latest advancement of Luminex’s line of microsphere-based multiplexed detection instruments based on the Company’s proprietary xMAP® technology. The Luminex 200 is designed to meet the multiplexed testing needs of the clinical and research laboratory professional. The Luminex […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
